1. Home
  2. PYPD vs ARAY Comparison

PYPD vs ARAY Comparison

Compare PYPD & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.27

Market Cap

81.7M

Sector

Health Care

ML Signal

HOLD

Logo Accuray Incorporated

ARAY

Accuray Incorporated

HOLD

Current Price

$0.34

Market Cap

68.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PYPD
ARAY
Founded
2008
1990
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.7M
68.6M
IPO Year
2014
2006

Fundamental Metrics

Financial Performance
Metric
PYPD
ARAY
Price
$4.27
$0.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$12.00
$3.50
AVG Volume (30 Days)
48.8K
1.4M
Earning Date
05-13-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.50
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$0.33
52 Week High
$5.12
$2.10

Technical Indicators

Market Signals
Indicator
PYPD
ARAY
Relative Strength Index (RSI) 46.09 30.10
Support Level $4.17 $0.33
Resistance Level $4.38 $0.63
Average True Range (ATR) 0.22 0.05
MACD 0.00 0.00
Stochastic Oscillator 25.95 6.54

Price Performance

Historical Comparison
PYPD
ARAY

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Share on Social Networks: